Suchergebnisse - "Drug Therapy, Combination/adverse effects"

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial

Autoren: Verstovsek, Srdan Foltz, Lynda Gupta, Vikas et al.

Quelle: Haematologica
Haematologica, Vol 108, Iss 10 (2023)
Verstovsek, S, Foltz, L, Gupta, V, Hasserjian, R, Manshouri, T, Mascarenhas, J, Mesa, R, Pozdnyakova, O, Ritchie, E, Veletic, I, Gamel, K, Hamidi, H, Han, L, Higgins, B, Trunzer, K, Uguen, M, Wang, D, El-Galaly, T C, Todorov, B & Gotlib, J 2023, 'Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis : stage I of a phase II trial', Haematologica, vol. 108, no. 10, pp. 2730-2742. https://doi.org/10.3324/haematol.2022.282411

Schlagwörter: Anemia, Fibrosis, Recombinant Proteins, 3. Good health, Drug Therapy, Combination/adverse effects, Primary Myelofibrosis/diagnosis, Treatment Outcome, Primary Myelofibrosis, Article - Myeloproliferative Disorders, Recombinant Proteins/adverse effects, Humans, Diseases of the blood and blood-forming organs, Drug Therapy, Combination, RC633-647.5

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37165840
https://doaj.org/article/853c9266e7f0447385d894bbf77cd11a
https://vbn.aau.dk/ws/files/551309018/11079-Article_Text-81045-2-10-20230926.pdf
http://www.scopus.com/inward/record.url?scp=85170267143&partnerID=8YFLogxK
https://vbn.aau.dk/da/publications/965feb45-9b9b-47b0-b264-8b4ca378ee3b
https://doi.org/10.3324/haematol.2022.282411

Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis

Autoren: Claudius Speer Christine Altenmüller-Walther Jan Splitthoff et al.

Quelle: Rheumatol Int

Schlagwörter: Dose-Response Relationship, Drug, Remission Induction, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Pneumonia, Observational Research, Disease-Free Survival, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Sepsis, Humans, Drug Therapy, Combination, Cyclophosphamide, Glucocorticoids, Immunosuppressive Agents, Dose-Response Relationship, Drug [MeSH], Immunosuppressive Agents/administration, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy [MeSH], Adverse effects, Humans [MeSH], Pneumonia/chemically induced [MeSH], Retrospective Studies [MeSH], Cyclophosphamide/adverse effects [MeSH], Cyclophosphamide/administration, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/mortality [MeSH], Recurrence [MeSH], Disease-Free Survival [MeSH], Drug Therapy, Combination/adverse effects [MeSH], Remission Induction [MeSH], Sepsis/chemically induced [MeSH], Glucocorticoids/administration, Glucocorticoids/adverse effects [MeSH], Immunosuppressive Agents/adverse effects [MeSH], ANCA-associated vasculitis, Retrospective Studies

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00296-020-04752-9.pdf
https://pubmed.ncbi.nlm.nih.gov/33222006
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835159
http://www.ncbi.nlm.nih.gov/pubmed/33222006
https://link.springer.com/content/pdf/10.1007/s00296-020-04752-9.pdf
https://pubmed.ncbi.nlm.nih.gov/33222006/
https://www.ncbi.nlm.nih.gov/pubmed/33222006
https://europepmc.org/article/PMC/PMC7835159
https://repository.publisso.de/resource/frl:6469218

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Autoren: Steg, Philippe Gabriel Bhatt, Deepak Simon, Tabassome et al.

Weitere Verfasser: Steg, Philippe Gabriel Bhatt, Deepak Simon, Tabassome et al.

Quelle: The New England Journal of Medicine, 381, 14, pp. 1309-1320
The New England journal of medicine, Vol. 381, no. 14, p. 1309-1320 (2019)
Steg, P G, Bhatt, D L, Simon, T, Fox, K, Mehta, S R, Harrington, R A, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Leonsson-Zachrisson, M, Liu, Y, Opolski, G, Zateyshchikov, D, Ge, J, Nicolau, J C, Corbalán, R, Cornel, J H, Widimský, P, Leiter, L A & THEMIS Steering Committee and Investigators 2019, 'Ticagrelor in Patients with Stable Coronary Disease and Diabetes', The New England Journal of Medicine, vol. 381, no. 14, pp. 1309-1320. https://doi.org/10.1056/NEJMoa1908077

Schlagwörter: Male, Ticagrelor, THEMIS Steering Committee and Investigators, CLINICAL BENEFIT, Myocardial Infarction, Coronary Artery Disease, Kaplan-Meier Estimate, SECONDARY PREVENTION, Stroke/epidemiology, 0302 clinical medicine, Hemorrhage/chemically induced, PRASUGREL, Cardiology - Radboud University Medical Center, 11 Medical and Health Sciences, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Incidence, DUAL ANTIPLATELET THERAPY, 60 MG, Middle Aged, 3. Good health, Drug Therapy, Combination/adverse effects, Stroke, Ticagrelor/adverse effects, Treatment Outcome, CLOPIDOGREL, Combination, Medicine, PLATELET INHIBITION, Drug Therapy, Combination, Female, Aged, Aspirin, Diabetes Mellitus, Type 2, Double-Blind Method, Follow-Up Studies, Hemorrhage, Humans, Platelet Aggregation Inhibitors, Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life Sciences, Life Sciences & Biomedicine, Type 2, Coronary Artery Disease/complications, Platelet Aggregation Inhibitors/adverse effects, General & Internal, Aspirin/adverse effects, 03 medical and health sciences, Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences, Medicine, General & Internal, Drug Therapy, General & Internal Medicine, Diabetes Mellitus, Myocardial Infarction/epidemiology, Internal Medicine - Radboud University Medical Center, CARDIOVASCULAR EVENTS, Science & Technology, Diabetes Mellitus, Type 2/complications, MYOCARDIAL-INFARCTION, COLLABORATIVE METAANALYSIS, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

Dateibeschreibung: application/pdf; 12 páginas

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/31475798
https://pubmed.ncbi.nlm.nih.gov/31475798/
https://www.narcis.nl/publication/RecordID/oai%3Arepository.ubn.ru.nl%3A2066%2F208849
http://www.diva-portal.org/smash/record.jsf?pid=diva2:1365374
https://www.nejm.org/doi/full/10.1056/NEJMoa1908077
https://www.nejm.org/doi/suppl/10.1056/NEJMoa1908077/suppl_file/nejmoa1908077_appendix.pdf
https://www.ncbi.nlm.nih.gov/pubmed/31475798
http://hdl.handle.net/10044/1/73277
https://hdl.handle.net/2066/208849
https://hdl.handle.net/2078.1/235243
https://hal.umontpellier.fr/hal-02859897v1
https://doi.org/10.1056/nejmoa1908077

Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study: a clinical randomized study

Autoren: Jan Gerstoft Birgit Røge Martin Schou Pedersen et al.

Quelle: Sølund, C, Andersen, E S, Mössner, B, Laursen, A L, Røge, B T, Kjær, M S, Gerstoft, J, Christensen, P B, Pedersen, M S, Schønning, K, Fahnøe, U, Bukh, J & Weis, N 2018, ' Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals : a clinical randomized study ', European journal of gastroenterology & hepatology, vol. 30, no. 10, pp. 1177–1186 . https://doi.org/10.1097/MEG.0000000000001192
Sølund, C, Andersen, E S, Mössner, B, Laursen, A L, Røge, B T, Kjær, M S, Gerstoft, J, Christensen, P B, Pedersen, M S, Schønning, K, Fahnøe, U, Bukh, J & Weis, N 2018, 'Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals : a clinical randomized study', European Journal of Gastroenterology and Hepatology, vol. 30, no. 10, pp. 1177-1186. https://doi.org/10.1097/MEG.0000000000001192

Schlagwörter: hepatitis C virus, Cyclopropanes, Male, Ritonavir/adverse effects, Benzimidazoles/adverse effects, Ribavirin/adverse effects, Hepacivirus, 0302 clinical medicine, 2-Naphthylamine, Headache/chemically induced, Anilides, Fatigue, Fluorenes/adverse effects, Headache, Anemia, Middle Aged, Hepatitis C, Antiviral Agents/adverse effects, ledipasvir and sofosbuvir, 3. Good health, Drug Therapy, Combination/adverse effects, Treatment Outcome, Fatigue/chemically induced, Drug Therapy, Combination, Female, Adult, Macrocyclic Compounds, Genotype, ribavirin, Lactams, Macrocyclic, Hepacivirus/genetics, Carbamates/adverse effects, Chronic/drug therapy, Antiviral Agents, 03 medical and health sciences, Hepatitis C, Chronic/drug therapy, Drug Therapy, Uracil/adverse effects, Anemia/chemically induced, Humans, Anilides/adverse effects, direct-acting antivirals, genotype 1, Fluorenes, Combination/adverse effects, paritaprevir, Sulfonamides/adverse effects, Hepatitis C, Chronic, ombitasvir and dasabuvir, Macrocyclic Compounds/adverse effects, adverse events, Viral Load/drug effects, randomized, Sofosbuvir/adverse effects, Benzimidazoles, Carbamates

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/29994874
http://europepmc.org/abstract/MED/29994874
https://www.ncbi.nlm.nih.gov/pubmed/29994874
https://portal.findresearcher.sdu.dk/da/publications/outcome-and-adverse-events-in-patients-with-chronic-hepatitis-c-t
https://forskning.ruc.dk/da/publications/outcome-and-adverse-events-in-patients-with-chronic-hepatitis-c-t
https://portal.findresearcher.sdu.dk/da/publications/7be08446-97ca-48b4-95c2-56accf2c03ec
https://portal.findresearcher.sdu.dk/da/publications/7be08446-97ca-48b4-95c2-56accf2c03ec
https://doi.org/10.1097/MEG.0000000000001192
https://pure.au.dk/portal/en/publications/55adba59-9f6e-426d-b2ba-548dd064dc6b
https://doi.org/10.1097/MEG.0000000000001192

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

Autoren: Cannon, Christopher Bhatt, Deepak Oldgren, Jonas et al.

Weitere Verfasser: Cannon, Christopher Bhatt, Deepak Oldgren, Jonas et al.

Quelle: Cannon, C P, Bhatt, D L, Oldgren, J, Lip, G Y H, Ellis, S G, Maeng, M, Merkely, B, Manassie, J, Januzzi, J L, Ten Berg, J M, Steg, P G, Hohnloser, S H & RE-DUAL PCI Steering Committee and Investigators 2017, 'Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation', The New England Journal of Medicine, vol. 377, no. 16, pp. 1513-1524. https://doi.org/10.1056/NEJMoa1708454

Schlagwörter: Male, Risk, Ticagrelor, Adenosine, Ticlopidine, Platelet Aggregation Inhibitors/therapeutic use, Hemorrhage, Warfarin/adverse effects, Ticlopidine/analogs & derivatives, 03 medical and health sciences, Percutaneous Coronary Intervention, 0302 clinical medicine, Kardiologi och kardiovaskulära sjukdomar, Adenosine/adverse effects, Hemorrhage/chemically induced, Atrial Fibrillation, Journal Article, Humans, Dabigatran/adverse effects, risk, Aged, clopidogrel, Aspirin, Atrial Fibrillation/drug therapy, Research Support, Non-U.S. Gov't, Incidence, percutaneous coronary intervention, Anticoagulants, ta3121, Middle Aged, Clopidogrel, Dabigatran, 3. Good health, Multicenter Study, Drug Therapy, Combination/adverse effects, Randomized Controlled Trial, Aspirin/therapeutic use, Purinergic P2Y Receptor Antagonists/adverse effects, incidence, Purinergic P2Y Receptor Antagonists, Drug Therapy, Combination, Female, Warfarin, Anticoagulants/adverse effects, Cardiology and Cardiovascular Disease, Platelet Aggregation Inhibitors

Dateibeschreibung: application/pdf; text

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/28844193
http://juuli.fi/Record/0284300917
https://doi.org/10.1056/NEJMoa1708454
https://vbn.aau.dk/en/publications/dual-antithrombotic-therapy-with-dabigatran-after-pci-in-atrial-fibrillation(c79b1379-6669-46c4-8a27-772303e6760d)/export.html
https://europepmc.org/article/MED/28844193
https://www.nejm.org/doi/full/10.1056/NEJMoa1708454
http://doi.org/10.1056/NEJMoa1708454
http://liu.diva-portal.org/smash/get/diva2:1187388/FULLTEXT01
https://lirias.kuleuven.be/1528094?limo=0
https://biblio.vub.ac.be/vubir/dual-antithrombotic-therapy-with-dabigatran-after-pci-in-atrial-fibrillation(758ecb87-0189-4abf-9bc4-1c09b8d1bcd8).html
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-145511
http://www.scopus.com/inward/record.url?scp=85031670044&partnerID=8YFLogxK
https://pure.au.dk/portal/en/publications/2f20e1eb-d1a4-44c3-989d-a162a17d3d9b
https://doi.org/10.1056/NEJMoa1708454

Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis

Autoren: Jayne, David RW Bruchfeld, Annette N Harper, Lorraine et al.

Weitere Verfasser: Jayne, David RW Bruchfeld, Annette N Harper, Lorraine et al.

Quelle: CLEAR Study Group 2017, 'Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis', Journal of the American Society of Nephrology : JASN, vol. 28, no. 9, pp. 2756-2767. https://doi.org/10.1681/ASN.2016111179

Schlagwörter: Adult, Male, 0301 basic medicine, Receptor, Anaphylatoxin C5a/antagonists & inhibitors, Anaphylatoxin C5a/antagonists & inhibitors, Nipecotic Acids, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Severity of Illness Index, 03 medical and health sciences, Prednisone/administration & dosage, 0302 clinical medicine, Drug Therapy, Double-Blind Method, Rituximab/therapeutic use, complement 5a, Aniline Compounds/adverse effects, Humans, complement, Cyclophosphamide, Glucocorticoids, Receptor, Anaphylatoxin C5a, Aged, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy, avacopan, Combination/adverse effects, Aniline Compounds, ANCA, complement 5a receptor, Glucocorticoids/administration & dosage, Middle Aged, Nipecotic Acids/adverse effects, 3. Good health, Drug Therapy, Combination/adverse effects, Cyclophosphamide/therapeutic use, Immunosuppressive Agents/therapeutic use, Prednisone, Drug Therapy, Combination, Female, ANCA-associated vasculitis, Rituximab, Immunosuppressive Agents, Receptor

Dateibeschreibung: application/pdf

Zugangs-URL: https://jasn.asnjournals.org/content/jnephrol/28/9/2756.full.pdf
https://pubmed.ncbi.nlm.nih.gov/28400446
https://research.manchester.ac.uk/en/publications/1b1cb70d-7fb0-4bfa-ae35-b06f840712a3
https://doi.org/10.1681/ASN.2016111179
https://research.birmingham.ac.uk/portal/en/publications/randomized-trial-of-c5a-receptor-inhibitor-avacopan-in-ancaassociated-vasculitis(e1386f3b-5a7a-4def-9bb3-d51ad430dd6d)/export.html
https://dial.uclouvain.be/pr/boreal/object/boreal:184332
https://europepmc.org/article/MED/28400446
http://www.diva-portal.org/smash/record.jsf?pid=diva2:1142417
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576933/
https://research.birmingham.ac.uk/portal/files/40145165/CLEAR_paper_JASN_final_2_.pdf
https://www.repository.cam.ac.uk/handle/1810/292730
https://doi.org/10.1681/asn.2016111179
https://doi.org/10.17863/cam.39887

Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients

Autoren: Rodríguez-Osorio, Iria Cid, Purificacion Morano, Luis et al.

Weitere Verfasser: Rodríguez-Osorio, Iria Cid, Purificacion Morano, Luis et al.

Quelle: RUC. Repositorio da Universidade da Coruña
instname

Schlagwörter: Aged, 80 and over, Male, Drug-Related Side Effects and Adverse Reactions, Hepatitis C, Chronic, Antiviral Agents/adverse effects, Antiviral Agents, Drug-Related Side Effects and Adverse Reactions/epidemiology, 3. Good health, Drug Therapy, Combination/adverse effects, 03 medical and health sciences, Hepatitis C, Chronic/drug therapy, Treatment Outcome, 0302 clinical medicine, Spain, Humans, Drug Therapy, Combination, Female, Prospective Studies, aged, 80 and over, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: https://ruc.udc.es/dspace/bitstream/2183/18395/3/Rodriguez_Real.pdf
https://pubmed.ncbi.nlm.nih.gov/28183063
http://hdl.handle.net/2183/18395
https://www.ncbi.nlm.nih.gov/pubmed/28183063
https://core.ac.uk/display/95053811
https://www.sciencedirect.com/science/article/pii/S1386653217300185
https://ruc.udc.es/dspace/handle/2183/18395
https://hdl.handle.net/2183/18395
https://hdl.handle.net/20.500.14017/06bbbe33-3ca2-4321-bf8b-02f96a55fb97
https://biblio.vub.ac.be/vubir/real-life-experience-with-directacting-antivirals-agents-against-hepatitis-c-infection-in-elderly-patients(06bbbe33-3ca2-4321-bf8b-02f96a55fb97).html
https://doi.org/10.1016/j.jcv.2017.01.003

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

Autoren: Verschueren, Patrick De Cock, Diederik Corluy, Luk et al.

Weitere Verfasser: Verschueren, Patrick De Cock, Diederik Corluy, Luk et al.

Quelle: Annals of the Rheumatic Diseases. 76:511-520

Schlagwörter: Isoxazoles/therapeutic use, Adult, Male, Methotrexate/adverse effects, Sulfasalazine/therapeutic use, Arthritis, Rheumatoid/blood, MONOTHERAPY, MULTICENTER, DMARD THERAPY, AMERICAN-COLLEGE, Antirheumatic Agents/adverse effects, Severity of Illness Index, RECOMMENDATIONS, Arthritis, Rheumatoid, SULFASALAZINE, 03 medical and health sciences, Prednisone/administration & dosage, 0302 clinical medicine, Risk Factors, MANAGEMENT, risk factors, Humans, Glucocorticoids, Aged, COMBINATION-TREATMENT STRATEGIES, 2. Zero hunger, C-Reactive Protein/metabolism, TIGHT CONTROL, Remission Induction, Glucocorticoids/administration & dosage, EARLY RA, Isoxazoles, Middle Aged, Prognosis, 3. Good health, Drug Therapy, Combination/adverse effects, Sulfasalazine, C-Reactive Protein, Methotrexate, Antirheumatic Agents, Prednisone, Drug Therapy, Combination, Female, Leflunomide

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/27432356
https://biblio.vub.ac.be/vubir/(bf5116ee-f2d9-4910-84f3-4f618e7b794e).html

Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes

Autoren: Christian Seerup Frandsen Thomas F. Dejgaard Ali Asmar et al.

Quelle: Dejgaard, T F, Johansen, N B, Frandsen, C S, Asmar, A, Tarnow, L, Knop, F K, Madsbad, S & Andersen, H U 2017, ' Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes ', Diabetes, Obesity and Metabolism Online, vol. 19, no. 5, pp. 734-738 . https://doi.org/10.1111/dom.12841

Schlagwörter: Male, type 1 diabetes, Diabetic Cardiomyopathies, Denmark, Drug Resistance, Blood Pressure, Carotid Intima-Media Thickness, Overweight/complications, Glycated Hemoglobin A/analysis, Hypoglycemic Agents/adverse effects, Body Mass Index, DOUBLE-BLIND, 0302 clinical medicine, cardiovascular disease, Risk Factors, Heart Rate, GLYCEMIC CONTROL, Liraglutide/adverse effects, Insulin, GLP-1 analogue, 2. Zero hunger, liraglutide, GLUCAGON-LIKE PEPTIDE-1, Diabetic Cardiomyopathies/diagnostic imaging, Heart Rate/drug effects, clinical trial, Middle Aged, INSULIN, 3. Good health, Drug Therapy, Combination/adverse effects, Cardiovascular Diseases, Insulin/therapeutic use, TRIAL, PARALLEL, Drug Therapy, Combination, Female, Adult, Cardiovascular Diseases/complications, Pulse Wave Analysis, Blood Pressure/drug effects, 03 medical and health sciences, Double-Blind Method, Journal Article, Humans, Hypoglycemic Agents, Glycated Hemoglobin, Diabetic Angiopathies/diagnostic imaging, Diabetes Mellitus, Type 1/blood, Liraglutide, Denmark/epidemiology, Diabetes Mellitus, Type 1, Diabetic Angiopathies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/27935240
https://www.infona.pl/resource/bwmeta1.element.wiley-dom-v-19-i-5-dom12841
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.12841
https://www.ncbi.nlm.nih.gov/pubmed/27935240
https://onlinelibrary.wiley.com/doi/abs/10.1111/dom.12841
https://pubmed.ncbi.nlm.nih.gov/27935240/
https://pure-portal.regsj.dk/da/publications/effects-of-liraglutide-on-cardiovascular-risk-factors-in-patients

Prescriptions médicamenteuses potentiellement inappropriées en gériatrie : quels outils utiliser pour les détecter ?

Autoren: Desnoyer, Aude Guignard, Bertrand Lang, Pierre-Olivier et al.

Quelle: La presse médicale, Vol. 45, No 11 (2016) pp. 957-970

Schlagwörter: ddc:615, ddc:617, Inappropriate Prescribing, Comorbidity, Drug Therapy, Combination / adverse effects, 03 medical and health sciences, 0302 clinical medicine, Geriatrics, Humans, Medication Errors, Drug Interactions, France, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: https://core.ac.uk/display/74464407
https://www.scilit.net/article/d146b577bf97448b20cf0e901303b99c
http://www.sciencedirect.com/science/article/pii/S075549821630207X
https://www.ncbi.nlm.nih.gov/pubmed/27633589
https://europepmc.org/article/MED/27633589
http://www.ncbi.nlm.nih.gov/pubmed/27633589
https://archive-ouverte.unige.ch/unige:90075
https://doi.org/10.1016/j.lpm.2016.06.033
https://archive-ouverte.unige.ch/unige:90075

Re-dual PCI - less bleeding with "double-dose treatment" with dabigatran compared to triple treatment with warfarin / Re-dual PCI - faerre blödningar med "dobbeltbehandling" med dabigatran sammenliknet med trippel behandling med warfarin

Autoren: Halvorsen, Sigrun

Quelle: Hjerteforum. 30(4):46

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

Autoren: Young, Jim Schäfer, Juliane Fux, Christoph A et al.

Weitere Verfasser: Young, Jim Schäfer, Juliane Fux, Christoph A et al.

Quelle: AIDS, Vol. 26, No 5 (2012) pp. 567-75

Schlagwörter: Adult, Cyclopropanes, Male, Ritonavir/adverse effects, Pyridines, Atazanavir Sulfate, HIV Infections/drug therapy, Kidney/drug effects/physiopathology, Organophosphonates, 610 Medicine & health, HIV Infections, Kidney, Glomerular Filtration Rate/drug effects, HIV Protease Inhibitors/administration & dosage/adverse effects, Lopinavir, 10234 Clinic for Infectious Diseases, 03 medical and health sciences, 0302 clinical medicine, Adenine/adverse effects/analogs & derivatives, Organophosphonates/adverse effects, Humans, Lopinavir/adverse effects, Reverse Transcriptase Inhibitors/administration & dosage/adverse effects, Pyridines/adverse effects, ddc:616, 2403 Immunology, Drug Therapy, Combination/adverse effects/methods, Adenine, Benzoxazines/adverse effects, 2725 Infectious Diseases, HIV Protease Inhibitors, Middle Aged, Benzoxazines, 3. Good health, Treatment Outcome, Alkynes, 2723 Immunology and Allergy, Reverse Transcriptase Inhibitors, Drug Therapy, Combination, Female, Oligopeptides, Oligopeptides/adverse effects, Glomerular Filtration Rate

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/22398568
http://www.infekt.ch/content/uploads/2013/11/Young_2012_Renal_function.pdf
https://archive-ouverte.unige.ch/unige:31635
https://pubmed.ncbi.nlm.nih.gov/22398568/
https://www.infekt.ch/content/uploads/2013/11/Young_2012_Renal_function.pdf
https://www.zora.uzh.ch/id/eprint/69394/
https://boris.unibe.ch/14958/
https://archive-ouverte.unige.ch/unige:31635
https://www.zora.uzh.ch/id/eprint/69394/
https://doi.org/10.5167/uzh-69394

Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008

Autoren: Ross J. Baldessarini Edwin Ho Ming Lee Mian-Yoon Chong et al.

Weitere Verfasser: Ross J. Baldessarini Edwin Ho Ming Lee Mian-Yoon Chong et al.

Quelle: The International Journal of Neuropsychopharmacology. 14:735-745

Schlagwörter: Adult, Male, Asia, Statistics as Topic, Physician's Practice Patterns, Diagnostic And Statistical Manual Of Mental Disorders, Benzodiazepines, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Humans, Drug Therapy, Combination - Adverse Effects, Statistics As Topic, Practice Patterns, Physicians', Psychotropic Drugs - Administration & Dosage - Adverse Effects - Therapeutic Use, Aged, Psychotropic Drugs, Benzodiazepines - Administration & Dosage - Adverse Effects - Therapeutic Use, Combination - Adverse Effects, Middle Aged, Practice Guidelines As Topic, 3. Good health, Diagnostic and Statistical Manual of Mental Disorders, Hospitalization, Cross-Sectional Studies, Practice Guidelines as Topic, Schizophrenia, Drug Therapy, Combination, Female, Schizophrenia - Drug Therapy - Physiopathology

Zugangs-URL: https://academic.oup.com/ijnp/article-pdf/14/6/735/2713448/14-6-735.pdf
https://pubmed.ncbi.nlm.nih.gov/21294941
https://europepmc.org/article/MED/21294941
https://academic.oup.com/ijnp/article/14/6/735/916161
https://hub.hku.hk/handle/10722/171963
http://hub.hku.hk/bitstream/10722/171963/1/Content.pdf
https://pubmed.ncbi.nlm.nih.gov/21294941/
https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201302297590930854
http://hdl.handle.net/10722/171963

Role of Dual-Hormone Closed-Loop Delivery System in the Future

Autoren: Lia Bally Roman Hovorka Hood Thabit

Quelle: Bally, L, Thabit, H & Hovorka, R 2016, 'Role of Dual-Hormone Closed-Loop Delivery System in the Future', Diabetes technology & therapeutics, vol. 18, no. 8, pp. 452-454. https://doi.org/10.1089/dia.2016.0259
Diabetes Technology & Therapeutics

Schlagwörter: Blood Glucose, Monitoring, Hormone Replacement Therapy, Type 1/blood, Hormone Replacement Therapy/adverse effects, Monitoring, Ambulatory, Hypoglycemia/chemically induced, 03 medical and health sciences, Insulin Infusion Systems, 0302 clinical medicine, Drug Therapy, Diabetes Mellitus, Insulin Infusion Systems/adverse effects, Humans, Hypoglycemic Agents, Insulin, Glucagon/administration & dosage, Hyperglycemia/chemically induced, Infusion Pumps, Randomized Controlled Trials as Topic, Combination/adverse effects, Diabetes Mellitus, Type 1/blood, Blood Glucose/analysis, Ambulatory/adverse effects, Hypoglycemic Agents/administration & dosage, Glucagon, Hypoglycemia, Drug Therapy, Combination/adverse effects, Infusion Pumps/adverse effects, Diabetes Mellitus, Type 1, Hyperglycemia, Drug Therapy, Combination, Drug Monitoring, Insulin/administration & dosage, Monitoring, Ambulatory/adverse effects

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/27500812
http://online.liebertpub.com/doi/10.1089/dia.2016.0259
https://europepmc.org/article/MED/27500812
https://boris.unibe.ch/90499/
https://core.ac.uk/display/79440469
http://www.liebertpub.com/doi/10.1089/dia.2016.0259
https://www.ncbi.nlm.nih.gov/pubmed/27500812

Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia

Autoren: Florentin, M. Kostapanos, M. S. Nakou, E. S. et al.

Quelle: Journal of Cardiovascular Pharmacology and Therapeutics. 14:274-282

Schlagwörter: Male, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Obesity/complications/*drug therapy, Overweight/complications/*drug therapy, Lactones/*administration & dosage, Anti-Obesity Agents/*administration & dosage, Lactones, 03 medical and health sciences, 0302 clinical medicine, Piperidines, Humans, Body Weight/drug effects, Obesity, Azetidines/*administration & dosage, Pyrazoles/*administration & dosage, Dyslipidemias, Orlistat, Anticholesteremic Agents, Body Weight, Dyslipidemias/complications/*drug therapy, Middle Aged, Overweight, Ezetimibe, Anticholesteremic Agents/*administration & dosage, 3. Good health, Drug Therapy, Combination/adverse effects, Piperidines/*administration & dosage, Azetidines, Pyrazoles, Drug Therapy, Combination, Female, Anti-Obesity Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Rimonabant

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/19724023
http://cpt.sagepub.com/lookup/doi/10.1177/1074248409343935
https://journals.sagepub.com/doi/abs/10.1177/1074248409343935
http://olympias.lib.uoi.gr/jspui/handle/123456789/22035

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke

Autoren: CAT Collaboration Circulatory Health JC onderzoeksprogramma Cardiovascular Health et al.

Weitere Verfasser: CAT Collaboration Circulatory Health JC onderzoeksprogramma Cardiovascular Health et al.

Schlagwörter: Male, Platelet Aggregation Inhibitors/adverse effects, Time Factors, Incidence, Research Support, Non-U.S. Gov't, Clinical Neurology, Brain Ischemia/drug therapy, Hemorrhage/epidemiology, 3. Good health, Drug Therapy, Combination/adverse effects, Journal Article, Humans, Female, Stroke/drug therapy, Aged, Randomized Controlled Trials as Topic, Meta-Analysis

Dateibeschreibung: image/pdf

Zugangs-URL: https://dspace.library.uu.nl/handle/1874/364702

World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis

Autoren: Ana Acuna-Villaorduna Oscar J. Ponce Celso De la Cruz-Luque et al.

Quelle: BMC Infect Dis
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-14 (2020)

Schlagwörter: Male, 0301 basic medicine, Ofloxacin, Clinical Biochemistry, Leprostatic Agents, Minocycline, Infectious and parasitic diseases, RC109-216, FOS: Health sciences, 0302 clinical medicine, Clinical Protocols, Recurrence, Antibiotics, Ciprofloxacin, Observational study, Treatment Failure, Antimicrobial Susceptibility Testing, Mycobacterium leprae/drug effects/isolation & purification, Child, Diagnosis and Treatment of Spinal Infections, Internal medicine, Neglected Diseases, Life Sciences, Middle Aged, 16. Peace & justice, 3. Good health, Drug Therapy, Combination/adverse effects, Mycobacterium leprae, Relative risk, Challenges in Understanding and Treating Leprosy, Infectious Diseases, Rifampin/adverse effects/therapeutic use, Randomized controlled trial, Leprosy, Multibacillary, Leprosy, Multibacillary/drug therapy, Medicine, Drug Therapy, Combination, Female, Rifampin, Research Article, Adult, Adolescent, Immunology, Leprostatic Agents/adverse effects/therapeutic use, World Health Organization, Microbiology, Microbial Identification and Diagnosis, 03 medical and health sciences, Leprosy, Paucibacillary/drug therapy, Biochemistry, Genetics and Molecular Biology, Leprosy, Health Sciences, Humans, Biology, Minocycline/adverse effects/therapeutic use, Aged, Regimen, FOS: Clinical medicine, Confidence interval, Neglected Diseases/drug therapy, Treatment, Meta-analysis, FOS: Biological sciences, Systematic review, Surgery, Leprosy, Paucibacillary, Ofloxacin/adverse effects/therapeutic use

Zugangs-URL: https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-019-4665-0
https://ddd.uab.cat/pub/artpub/2020/pmc_31959113/pmc_31959113.pdf
https://pubmed.ncbi.nlm.nih.gov/31959113
https://doaj.org/article/5a67d8905394407991036a0cc217ad80
https://www.ncbi.nlm.nih.gov/pubmed/31959113
https://jglobal.jst.go.jp/en/detail?JGLOBAL_ID=202002238326863183
https://einstein.pure.elsevier.com/en/publications/world-health-organization-who-antibiotic-regimen-against-other-re
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971933/
https://pubmed.ncbi.nlm.nih.gov/31959113/
https://link.springer.com/article/10.1186/s12879-019-4665-0
https://hdl.handle.net/20.500.12866/8323
https://doi.org/10.1186/s12879-019-4665-0

Bilateral rupture of the Achilles tendons after treatment with ciprofloxacin / Bilateral akillesseneruptur efter behandling med ciprofloxacin

Autoren: Attarzadeh, Amir Pasha Ryge, Camilla

Quelle: Ugeskrift for Laeger. 175(39):2264

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

Autoren: Cometta, A. Baumgartner, J. D. Lew, Daniel Pablo et al.

Quelle: Antimicrobial Agents and Chemotherapy, Vol. 38, No 6 (1994) pp. 1309-1313

Schlagwörter: Netilmicin/adverse effects/therapeutic use, Adult, Male, 0301 basic medicine, Drug Therapy, Combination/adverse effects/ therapeutic use, Bacteremia, Peritonitis, 03 medical and health sciences, 0302 clinical medicine, Bacteremia/drug therapy, Humans, Netilmicin, Prospective Studies, Aged, ddc:616, Cross Infection, Bacterial Infections, Pneumonia, Middle Aged, Cross Infection/drug therapy, Pneumonia/drug therapy, 3. Good health, Imipenem/adverse effects/ therapeutic use, Imipenem, Drug Therapy, Combination, Female, Peritonitis/drug therapy, Bacterial Infections/ drug therapy

Dateibeschreibung: application/pdf

Zugangs-URL: https://aac.asm.org/content/38/6/1309.full.pdf
https://pubmed.ncbi.nlm.nih.gov/8092830
http://europepmc.org/articles/PMC188203
https://www.ncbi.nlm.nih.gov/pubmed/8092830
https://aac.asm.org/content/38/6/1309.short
https://archive-ouverte.unige.ch/unige:7150
https://journals.asm.org/doi/pdf/10.1128/AAC.38.6.1309
https://archive-ouverte.unige.ch/unige:7150
https://doi.org/10.1128/aac.38.6.1309
https://archive-ouverte.unige.ch/unige:7150

Diabetes type 2 and hypoglycemia / Typ 2 och hypglykemi

Autoren: Ahrén, Bo

Quelle: Diabetes (Stockholm). (1):18